Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control-Reference-Cited by-同舟云学术

Integrated genomic analysis of triple-negative breast cancers reveals novel microRNAs associated with clinical and molecular phenotypes and sheds light on the pathways they control

Published:2013 Issue:1 Volume:14 Page:643
ISSN:1471-2164
Container-title:BMC Genomics
language:en
Short-container-title:BMC Genomics

Author:

de Rinaldis Emanuele,Gazinska Patrycja,Mera Anca,Modrusan Zora,Fedorowicz Grazyna M,Burford Brian,Gillett Cheryl,Marra Pierfrancesco,Grigoriadis Anita,Dornan David,Holmberg Lars,Pinder Sarah,Tutt Andrew

Publisher

Springer Science and Business Media LLC

Subject

Genetics,Biotechnology

Reference45 articles.

1. Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes

2. Race, Breast Cancer Subtypes, and Survival in the Carolina Breast Cancer Study

3. MicroRNA Gene Expression Deregulation in Human Breast Cancer

4. MicroRNAs and their target gene networks in breast cancer

5. MicroRNA Isolation from Formalin-Fixed, Paraffin-Embedded Tissues

Cited by 80 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PAK6 acts downstream of IQGAP3 to promote contractility in triple negative breast cancer cells;Cellular Signalling;2024-09

2. Deregulated MicroRNAs involved in P53 Signaling Pathway in Breast Cancer with Focus on Triple-negative Breast Cancer;Current Molecular Pharmacology;2023-11-03

3. MicroRNA-409-5p Inhibits GIST Tumorigenesis and Improves Imatinib Resistance by Targeting KDM4D Expression;Current Medical Science;2023-10

4. miRNAs driving diagnosis, prognosis and progression in Merkel cell carcinoma;Pathology - Research and Practice;2023-09

5. Repression of miR-146a in predicting poor treatment outcome in triple-negative breast cancer;Clinical Biochemistry;2023-04